MYNZ — Mainz Biomed NV Balance Sheet
0.000.00%
Last trade - 00:00- $6.98m
- $2.99m
- $0.89m
- 39
- 23
- 14
- 13
Annual balance sheet for Mainz Biomed NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.123 | 8.73 | 17.1 | 7.07 | 6.24 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.044 | 0.112 | 0.259 | 0.355 | 0.214 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.186 | 9.61 | 18.4 | 8.98 | 7.84 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.487 | 0.432 | 1.84 | 3.03 | 2.38 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.673 | 10 | 20.2 | 15.4 | 13.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.702 | 1.35 | 4.24 | 9.24 | 5.95 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.41 | 3.68 | 6.14 | 12.2 | 7.19 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -2.74 | 6.36 | 14.1 | 3.25 | 6.05 |
| Total Liabilities & Shareholders' Equity | 0.673 | 10 | 20.2 | 15.4 | 13.2 |
| Total Common Shares Outstanding |